Wednesday, 30 January 2019
Regeneus' newly-appointed CEO Leo Lee discusses strategic plans for growth
Interview with Proactive Investors
Leo Lee, the newly-appointed CEO of Regeneus Ltd (ASX:RGS), speaks to Proactive Investors about the Australian clinical-stage regenerative medicine company's operations, and the wider scientific field.